Acetaminophen Injection
Labeling: Label Mix-up: a bag of Dexmedetomidine HCl in 0.9% Sodium Chloride Injection was found inside an overwrap labeled Acetaminophen Injection 1,000 mg per 100 mL (10 mg/mL)
Class I is the FDA's most serious recall category: a reasonable probability that using the product will cause serious health consequences or death. It is a small share of all recalls, but the one to check first if a medication you take appears here.
1,750 recalls, newest first.
Labeling: Label Mix-up: a bag of Dexmedetomidine HCl in 0.9% Sodium Chloride Injection was found inside an overwrap labeled Acetaminophen Injection 1,000 mg per 100 mL (10 mg/mL)
Failed Dissolution Specifications
Labeling: Label Mix-Up: Some bottles of Acetaminophen Extra Strength 500 mg tablets were incorrectly labeled with the drug facts label for Aspirin 81 mg tablets.
Microbial Contamination of Non-Sterile Products: multiple Bacillus species organisms
Failed Dissolution Specifications
Failed Dissolution Specifications
Presence of Particulate Matter: Presence of particulate matter from the stopper in the drug product.
Presence of Particulate Matter: Presence of particulate matter from the stopper in the drug product.
Microbial Contamination of Non-Sterile Products: Presence of Aspergillus Sydowii (Mold)
Labeling: Label mix-up - ephedrine syringes mislabeled as phenylephrine.
Marketed Without An Approved NDA/ANDA
Labeling: Label Mix-up - product labeled as tirzepatide contains testosterone cypionate
Sub-potent Drug; powder discoloration associated with decreased potency
Sub-potent Drug; powder discoloration associated with decreased potency
Microbial contamination of a non-sterile product: potential Bacillus cereus contamination.
Chemical Contamination: Product manufactured with ethanol API that contains methanol
Chemical Contamination: Product manufactured with ethanol API that contains methanol
Superpotent Drug: Due to overfilling of drug powder
Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.
Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.
Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.
Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.
Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.
Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.
Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.